Instrument Inactif

Autres langues Stem Cell Therapeutics Corp. Xetra

Actions

R5W

CA8585721001

Cours en clôture Xetra
- ^EUR	-

12/01/22	TCR2 Therapeutics nomme un directeur des affaires et de la stratégie	MT
13/12/21	Pfizer veut renforcer son expertise dans le domaine des maladies immuno-inflammatoires en rachetant Arena Pharmaceuticals pour 6,7 milliards de dollars.	MT

Autres langues

12/01/22	TCR2 Therapeutics Appoints Chief Business and Strategy Officer
13/12/21	Pfizer Deploying Some of Its Covid Cash in Arena Deal -- Analysis
13/12/21	Pfizer Eyes Enhanced Immuno-Inflammatory Disease Expertise With $6.7 Billion Arena Pharmaceuticals Takeover
13/12/21	Pfizer schluckt kalifornische Biotechfirma für 6,7 Mrd Dollar
13/12/21	Pfizer scommette su promettente farmaco Arena con deal da 6,7 mld $
19/11/21	Trillium Therapeutics Inc.(TSX:TRIL) dropped from S&P Global BMI Index
17/11/21	Trillium Therapeutics : Pfizer Completes Acquisition of Trillium Therapeutics - Form 8-K
17/11/21	Pfizer Completes $2.22 Billion Trillium Therapeutics Acquisition
17/11/21	TRILLIUM THERAPEUTICS INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)
17/11/21	Trillium Therapeutics Inc. Announces Executive Changes
17/11/21	Trillium Therapeutics Inc. Announces Resignation of Jan Skvarka as Chief Executive Officer
17/11/21	Trillium Therapeutics Inc. Announces Cessation of James Parsons as Chief Financial Officer
17/11/21	Pfizer-Trillium Therapeutics $2.26 Billion Deal Secures Canada, US Approval
17/11/21	Trillium Therapeutics Inc.(NasdaqCM:TRIL) dropped from NASDAQ Composite Index
17/11/21	Pfizer Inc. completed the acquisition of remaining 97.8% stake in Trillium Therapeutics Inc. from New Enterprise Associates 16, L.P., a fund managed by New Enterprise Associates, Inc., Avoro Capital Advisors LLC, RA Capital Healthcare Fund, L.P., a fund managed by RA Capital Management, L.P. and others.
16/11/21	TRILLIUM THERAPEUTICS INC. : Other Events (form 8-K)
12/11/21	Trillium: Q3 Earnings Snapshot
12/11/21	Trillium Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
12/11/21	TRILLIUM THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
29/10/21	Trillium Therapeutics Receives Final Court Order Approving Arrangement - Form 8-K
29/10/21	TRILLIUM THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
28/10/21	Trillium Therapeutics Brief: Says Received Final Court Order Approving Arrangement With PF Argentum ULC, a wholly-owned, indirect subsidiary of Pfizer Inc
28/10/21	Trillium Therapeutics Receives Final Court Order Approving Arrangement
27/10/21	Trillium Securityholders Approve Acquisition by Pfizer - Form 8-K
27/10/21	TRILLIUM THERAPEUTICS INC. : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)